2022
DOI: 10.1055/s-0042-1742736
|View full text |Cite
|
Sign up to set email alerts
|

Overview of Biologic Agents Used in Skin and Soft Tissue Reconstruction

Abstract: Wound healing is a highly complex process mediated by cellular interactions at the microscopic level. Increased understanding of wound healing physiology has served as the foundation for translational research to develop biologic wound care technologies that have profoundly affected patient care. As the reader will see throughout this series in Seminars in Plastic Surgery, biologic wound technologies have broad applications and have greatly impacted the reconstructive ladder. Despite their frequent use, many s… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 52 publications
(67 reference statements)
0
1
0
Order By: Relevance
“… 15 Various expensive skin substitutes and wound dressings have also been developed; however, their effectiveness is currently limited. 16 NPWT with instillation and dwelling, which has the additional function of continuous wound cleansing, is gradually becoming more available. 17 This also has significant healthcare economic disadvantages.…”
Section: Discussionmentioning
confidence: 99%
“… 15 Various expensive skin substitutes and wound dressings have also been developed; however, their effectiveness is currently limited. 16 NPWT with instillation and dwelling, which has the additional function of continuous wound cleansing, is gradually becoming more available. 17 This also has significant healthcare economic disadvantages.…”
Section: Discussionmentioning
confidence: 99%
“…Although their indications for use have substantially broadened, biologic wound treatments were traditionally used in burn and abdominal wall restoration [43]. Several dermoinductive and dermoconductive wound agents have currently been approved by the United States Food and Drug Association (FDA) for the purpose of soft tissue reconstruction; nevertheless, many reconstructive surgeons use them off-label to fix defects not explicitly permitted by the FDA [44].…”
Section: Applicationsmentioning
confidence: 99%